Financial Data and Key Metrics Changes - The first quarter results for 2025 were disappointing, with GAAP net investment income and core NII at $6,800,000 or $0.02 per share, down from $8,000,000 or $0.03 per share in Q4 2024 [6][19] - NAV per share decreased by approximately 1.6% to $12.11 from the prior quarter, impacted by net realized losses and markdowns totaling $2,600,000 [6][19] - The weighted average effective yield on income-producing debt investments decreased to 12.1% from 12.5% in the previous quarter [9][19] Business Line Data and Key Metrics Changes - Gross capital deployments in Q1 totaled $45,500,000, with net deployments of $26,100,000 after repayments and sales of $19,400,000 [6][9] - The portfolio mix at the end of Q1 was approximately 90.3% first lien, senior secured debt, with a mix of 2:3 sponsor to non-sponsor deals [8][9] - Nonaccrual investments increased to 8.8% of the debt portfolio from 7.2% in the prior quarter [13][19] Market Data and Key Metrics Changes - The STRS JV portfolio had an aggregate fair value of $310,200,000, with an average effective yield of 10.8%, down from 11.1% in Q4 [9][21] - The lending market has seen increased volatility, with a 25 to 50 basis point increase in direct lending market prices, although most of that premium has dissipated [15][19] - The M&A market has slowed significantly, with many deals being put on hold due to negative sentiment and tariff negotiations [14][45] Company Strategy and Development Direction - The company continues to focus on the non-sponsor market, where there are better risk-return profiles and less competition [16][19] - A new coverage region was added in Nashville, Tennessee, to enhance non-sponsor and off-the-run sponsor origination capabilities [16][19] - The company is actively monitoring tariff risks and has expanded its analysis to include other countries with potential tariffs [11][19] Management's Comments on Operating Environment and Future Outlook - Management noted that challenges in the quarter were more company-specific rather than related to the overall economy, with no signs of a recession yet in the portfolio [10][19] - The company expects a decent amount of refinancing activity in the second half of the year as prepayment penalties on higher-rate deals expire [51][19] - Management is cautious about the environment for deal closures in Q3, anticipating a relative quiet period [46][19] Other Important Information - The company declared a first-quarter distribution of $0.03 per share, consistent with the prior quarter, and will continue to evaluate quarterly distributions based on core earnings power [24][19] - Cash resources at the end of Q1 were approximately $19,600,000, with an asset coverage ratio of 177.2%, above the minimum requirement [22][19] Q&A Session Summary Question: Update on Telestream and its return to accrual status - Management indicated progress on restructuring Telestream, hoping to complete it by May, which would allow a portion of the existing debt to return to cash-paying status [28][19] Question: Insights on dividend and spillover income - Spillover income was approximately $28,400,000, with a current dividend run rate equating to about $8,950,000 in distributions, highlighting a shortfall in Q1 [39][19] Question: Market conditions regarding bid-ask spreads - Management noted that good companies without significant risks are trading at high multiples, while those with recession or tariff risks are seeing buyers being cautious [44][19] Question: Expectations on repayment activity - Management observed a slowdown in repayment activity due to recent market volatility, with a light visible repayment pipeline currently [53][19]

Vaxart (VXRT) Q1 2025 Earnings Call May 13, 2025 04:30 PM ET Company Participants Edward Berg - Senior Vice President and General CounselSteven Lo - CEO , President & DirectorJames Cummings - Chief Medical OfficerSean Tucker - Founder & Chief Scientific OfficerPhillip Lee - Chief Financial OfficerCheng Li - Director - Equity ResearchMayank Mamtani - Senior Managing Director & Group Head of HealthcareLiang Cheng - Senior Research Associate Operator Greetings. Welcome to Vaxart Business Update and First Quart ...

Vaxart (VXRT) Q1 2025 Earnings Call May 13, 2025 04:30 PM ET Speaker0 Greetings. Welcome to Vaxart Business Update and First Quarter twenty twenty five Financial Results Conference Call. A question and answer session will follow management's opening remarks. Individual investors may submit written questions to vaxart.com. As a reminder, this conference is being recorded. I would now like to turn the webcast over to your host, Ed Berg, Senior Vice President and General Counsel. Speaker1 Good afternoon, and w ...

Core Insights - Alico, Inc. is transitioning to become a diversified land company, concluding its capital investment in citrus operations after the fiscal year 2025 harvest [1][2] - The company has raised its land sales outlook to potentially exceed $50 million for fiscal year 2025, supported by ongoing negotiations and agreements [1][2][25] - Alico's financial guidance now includes cash balance, net debt, and adjusted EBITDA targets for fiscal year 2025, projecting a cash balance of approximately $25 million and net debt of around $60 million [1][2][26] Financial Performance - For the second quarter ended March 31, 2025, Alico reported revenue of $17.98 million, a slight decrease of 0.7% compared to $18.11 million in the same period of 2024 [3] - The net loss attributable to Alico common stockholders for the quarter was $111.4 million, a significant increase from a loss of $15.8 million in the prior year, primarily due to accelerated depreciation and impairment related to the strategic transformation [4][5] - Adjusted EBITDA for the second quarter was $12.7 million, contrasting with a loss of $16.5 million in the same quarter of 2024 [5] Citrus Operations - Alico completed its last major citrus harvest in April 2025, with plans for a final harvest on remaining operational citrus groves in fiscal year 2026 [2][24] - Citrus production saw a decline, with total processed boxes down 20.4% year-over-year for the three months ended March 31, 2025 [7] - The company experienced a significant drop in pound solids harvested due to adverse weather conditions, specifically Hurricane Milton [7] Land Management and Other Operations - Revenue from Land Management and Other Operations increased by 107.1% for the three months ended March 31, 2025, driven by higher rock and sand royalty income [10] - Operating expenses in this segment decreased by 46.5% compared to the same period in 2024, primarily due to lower property taxes following the sale of Alico Ranch [11] Strategic Initiatives - Alico is developing the Corkscrew Grove Villages project, which will encompass approximately 4,660 acres and aims to provide residential and commercial opportunities while enhancing public infrastructure [17][18] - The company has initiated a multi-year entitlement approval process for the Corkscrew Grove Villages, with the first village's approval expected in 2026 [18] - Alico's commitment to conservation is evident in its plans to place an additional 6,000 acres into permanent conservation as part of the Corkscrew Grove Villages project [21][22] Liquidity and Financial Position - As of March 31, 2025, Alico reported a robust liquidity position with $14.7 million in cash and cash equivalents and $88.5 million in available credit facilities [1][19] - The company's working capital was $36.1 million, reflecting a current ratio of 5.56 to 1.00 [19] - Total debt stood at $89.6 million, with net debt at $74.9 million, showing a decrease from the previous fiscal year [19]

WhiteHorse Finance, Inc. Earnings Presentation Quarter Ended March 31, 2025 NASDAQ: WHF (Common Stock) NASDAQ: WHFCL (7.875% Notes due 2028) Important Information and Forward Looking Statements References in this presentation to "WHF", "WhiteHorse Finance", "we", "us", "our" and "the Company" refer to WhiteHorse Finance, Inc. This presentation and the information and views included herein do not constitute investment advice, or a recommendation or an offer to enter into any transaction with the Company or a ...

Core Insights - Vaxart, Inc. has resumed screening for the 10,000 participant portion of its COVID-19 Phase 2b trial, with dosing expected to start in Q2 2025 [4][7] - The company completed enrollment for its Phase 1 clinical trial of a second-generation oral norovirus vaccine, with topline data anticipated in mid-2025 [4][7] - A new avian influenza vaccine candidate demonstrated 100% protection in a ferret challenge model, contrasting with 0% survival in placebo-treated animals [9] COVID-19 Vaccine Developments - The stop work order for the COVID-19 Phase 2b trial was lifted, allowing Vaxart to proceed with participant screening [4][7] - The company is operating under a Project NextGen award, potentially receiving up to $460.7 million, with $240.1 million currently available [7] - Screening for the trial is currently underway, with dosing expected to begin in the second quarter of 2025 [7] Norovirus Vaccine Developments - Vaxart completed enrollment of 60 participants in its Phase 1 trial for the second-generation oral norovirus vaccine, with results expected in mid-2025 [7] - An independent Data and Safety Monitoring Board recommended the continuation of the study without modifications [7] Avian Influenza Program Developments - The new avian influenza vaccine candidate showed 100% protection against death in a ferret model, with plans to publish the findings in a peer-reviewed forum [9] Financial Results - For Q1 2025, Vaxart reported revenue of $20.9 million, a significant increase from $2.2 million in Q1 2024 [12][18] - Research and development expenses rose to $30.7 million in Q1 2025, compared to $19.0 million in Q1 2024, primarily due to increased clinical trial costs [12][18] - The net loss for Q1 2025 was $15.6 million, an improvement from a net loss of $24.4 million in Q1 2024, with a net loss per share of $0.07 compared to $0.14 in the previous year [12][18][19] Leadership Changes - Jeroen Grasman has been appointed as Chief Financial Officer effective May 19, 2025, succeeding Phillip Lee, who will remain as a non-executive employee until June 1, 2025 [12]

Core Viewpoint - InterDigital (IDCC) is positioned as a strong investment opportunity due to significant revisions in earnings estimates, indicating a positive earnings outlook and potential for continued stock price gains [1][2]. Earnings Estimate Revisions - Analysts have shown increasing optimism regarding InterDigital's earnings prospects, leading to higher earnings estimates which are expected to positively influence the stock price [2]. - The consensus earnings estimate for the current quarter is $2.51 per share, reflecting a decrease of 45.08% from the previous year, but has increased by 66.89% over the last 30 days with no negative revisions [7]. - For the full year, the expected earnings are $11.75 per share, which is a decrease of 21.51% from the prior year, yet the consensus estimate has risen by 15.23% due to three upward revisions and no negative changes [8][9]. Zacks Rank and Performance - InterDigital has achieved a Zacks Rank of 2 (Buy), indicating favorable estimate revisions that suggest strong potential for stock performance [10]. - Historically, stocks with a Zacks Rank of 1 (Strong Buy) and 2 (Buy) have significantly outperformed the S&P 500, with Zacks 1 stocks averaging a 25% annual return since 2008 [3][10]. Recent Stock Performance - Over the past four weeks, InterDigital shares have increased by 7.8%, reflecting investor confidence in the company's earnings growth prospects driven by the positive estimate revisions [11].

Together with Blackstone Secured Lending Fund ( BXSL ) , which I covered this month, Hercules Capital Inc. (NYSE: HTGC ) is my preferred choice in the market for business development companies right now, primarily because the BDC offers passive investors a solidA financial researcher and avid investor with a keen eye for innovation and disruption, as well as growth buy-outs and value stocks. Keeping an eye on the pace of high tech and early growth companies, I write about current events and the biggest news ...

The St. Joe Company (JOE) FY 2025 Annual General Meeting May 13, 2025 10:00 AM ET Speaker0 Good morning. I'm George Gonzales, President, CEO and Chairman of the St. Joe Company. It's my pleasure to welcome you to our twenty twenty five Annual Shareholder Meeting. In accordance with the notice of meeting, I officially call the meeting to order, at this time. We will conduct this meeting in accordance with the agenda you were given when you registered this morning. If you have not registered, please do so at ...

ANNUAL MEEING OF SHAREHOLDERS May 13, 2025 CONSISTENT BUSINESS STRATEGY Expand portfolio of recurring income producing commercial and hospitality properties Develop residential communities with long term, scalable and repeatable revenue Multi-faceted capital allocation between capital expenditures for business growth, debt reduction, and stock repurchases Steady and growing dividend program HOW JOE IS POSITIONED 87% OF THE 167,000 ACRES OWNED ARE IN BAY, WALTON AND GULF COUNTIES ENTITLEMENTS TO DEVELOP OVER ...